Skip to main content

Table 1 Laboratory data

From: Multidisciplinary intervention for adverse events associated with ATZ + BEV therapy: a case report

Day0

 WBC

7800

/μL

AST

31

U/L

 RBC

405

×103/μL

ALT

60

U/L

 Hb

10.7

g/dL

ALP

197

U/L

 Ht

33.5

%

γ-GTP

77

U/L

 Plt

501

×103/μL

T-Bil

0.4

mg/dL

 Lympho

33.5

%

LDH

220

U/L

 AFP

1

ng/mL

Alb

2.8

g/dL

 PIVKA-II

923

mAU/mL

Na

139

mEq/L

 FT4

1.24

ng/dL

K

4.3

mEq/L

 FT3

3.14

pg/mL

Cl

105

mEq/L

 TSH

2.34

mIU/L

BUN

25

mg/dL

 Cortisol

15.4

μg/dL

Cre

1.13

mg/dL

 ACTH

19.7

pg/mL

eGFR

49.5

ml/min

Day22

 WBC

6800

/μL

AST

43

U/L

 RBC

340

×103/μL

ALT

72

U/L

 Hb

9.1

g/dL

ALP

144

U/L

 Ht

28.4

%

γ-GTP

83

U/L

 Plt

473

×103/μL

T-Bil

0.5

mg/dL

 Lympho

24.5

%

LDH

213

U/L

 Cortisol

15.5

μg/dL

Alb

2.5

g/dL

 ACTH

26.1

pg/mL

Na

131

mEq/L

   

K

4.6

mEq/L

   

Cl

100

mEq/L

   

BUN

16

mg/dL

   

Cre

0.81

mg/dL

   

eGFR

71.3

ml/min

  1. ACTH adrenocorticotropic hormone, AFP alpha-hetoprotein, Alb albumin, ALP alkaline phosphatase, ALT alanine aminotransferase, AST aspartate aminotransferase, BUN blood urea nitrogen, CCr creatinine clearance, Cl chloride, CRP C-reactive protein, FT free thyroxine, GFR estimated glomerular filtration rate, Hb hemoglobin, Ht hematocrit, K potassium, lympho lymphocyte, Na sodium, PLT platelet, RBC red blood cell, T-Bil total bilirubin, Tg thyroglobulin, TSH thyroid-stimulating hormone, WBC white blood cell